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Abstract 
Background: In the light of demographic developments health promotion interventions for older people are gain‑
ing importance. In addition to methodological challenges arising from the economic evaluation of health promotion 
interventions in general, there are specific methodological problems for the particular target group of older people. 
There are especially four main methodological challenges that are discussed in the literature. They concern measure‑
ment and valuation of informal caregiving, accounting for productivity costs, effects of unrelated cost in added life 
years and the inclusion of ‘beyond‑health’ benefits. This paper focuses on the question whether and to what extent 
specific methodological requirements are actually met in applied health economic evaluations.
Methods: Following a systematic review of pertinent health economic evaluations, the included studies are analysed 
on the basis of four assessment criteria that are derived from methodological debates on the economic evaluation of 
health promotion interventions in general and economic evaluations targeting older people in particular.
Results: Of the 37 studies included in the systematic review, only very few include cost and outcome categories 
discussed as being of specific relevance to the assessment of health promotion interventions for older people. The 
few studies that consider these aspects use very heterogeneous methods, thus there is no common methodological 
standard.
Conclusion: There is a strong need for the development of guidelines to achieve better comparability and to include 
cost categories and outcomes that are relevant for older people. Disregarding these methodological obstacles could 
implicitly lead to discrimination against the elderly in terms of health promotion and disease prevention and, hence, 
an age‑based rationing of public health care.
Keywords: Economic evaluation, Health promotion, Primary prevention, Older people
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Main text
Background
In the light of current demographic developments in 
most of the OECD countries health promotion inter-
ventions for older people are gaining importance. In 
the past, health promotion interventions have largely 
been focussed on children, young people and the work-
ing population. Now, the growing proportion of older 
people in the population of many OECD countries and 
the increase in their respective share of national health 
budget expenditure has amplified interest in health pro-
motion interventions for older people. To justify the 
political implementation of these programmes there 
is a growing demand for health economic evaluations 
of health promotion interventions for older people, 
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and the number of respective studies—though still not 
large—has increased considerably in recent years. These 
studies face several challenges. Alongside general meth-
odological obstacles pertaining to the health economic 
evaluation of health promotion or public health inter-
ventions in general (e.g. [1]), there are obstacles to the 
health economic evaluation of health promotion inter-
ventions that specifically concern older people and that, 
if not considered appropriately, may disadvantage them. 
The general problems concern, for example, the attribu-
tion of effects, as it is more difficult to conduct rand-
omized controlled trials against the background of the 
long time horizon of many of these interventions, as 
well as the fact that many of them are directed at popu-
lations or communities, while principles of evidence 
based medicine demand that relevant effects are proven 
for individuals [1, 2].
This paper focuses on the question to what extent 
specific requirements or methodological challenges of 
health economic evaluations of health promotion or 
preventive interventions for older people are taken into 
account in applied health economic evaluations. A sum-
mary of the main methodological challenges for the 
economic evaluation of health promotion interventions 
for older people that are discussed in the theoretical 
and methodological literature on economic evaluation 
will be presented in the following section. Following a 
more detailed analysis published in Huter et al. [3] four 
challenges emerge that are of specific relevance for the 
economic assessment of health promotion interventions 
for older people. These aspects may bias study results 
and thus severely affect the comparability of the results 
with results of health economic evaluations of inter-
ventions for other age groups or for different types of 
interventions. Accounting for them is crucial if studies 
are meant to serve as starting points for policy decisions 
concerning the allocation of resources for competing 
programmes.
To examine if and how these identified methodo-
logical requirements are taken into account in applied 
health economic studies, we draw on a systematic 
review on health economic evaluations of health pro-
motion and primary prevention interventions for older 
people [4], which has been updated for this study and 
whose data is reanalysed with respect to the previously 
identified criteria. They are used to assess whether and 
how the methodological problems have been tack-
led in existing studies. The results of this analysis are 
then presented and discussed. As the results are very 
diverse they are described qualitatively. We close with 
a short appreciation of measures that would be needed 
to address the identified shortcomings of the existing 
research.
Main methodological challenges
The application of economic evaluation methods to 
health promotion interventions for older people encoun-
ters numerous methodological problems. These prob-
lems derive from three sources: (1) controversies related 
to economic evaluation methods themselves; (2) the dis-
tinctive design of health promotion programmes and (3) 
special features of older people as a target group.
General methodological problems pertaining to eco-
nomic evaluations of health promotion interventions 
have been widely discussed [1, 5–9]: health promo-
tion interventions in general tend to have a broader 
focus than curative interventions; their targets may not 
be limited to individual health gains but may also com-
prise social benefits or ‘beyond-health’ benefits for the 
individual and broader effects on the family, community 
or society as a whole. Health promotion activities may 
involve many different sectors, like education, housing, 
transportation, the environmental or social sector; many 
interventions rely on volunteer work or specific com-
munity involvement. The effects of many health promo-
tion interventions are expected to unfold in a long-term 
perspective. For all these reasons a societal perspective is 
often recommended for health economic evaluations of 
health promotion, and sometimes generally required, as 
e.g. in the Netherlands and Sweden [6, 7, 10]. This implies 
the inclusion of a broad range of costs and benefits and 
builds the prerequisite of our argumentation.
An analysis of the literature on methodological prob-
lems of health economic evaluation targeting older peo-
ple, health economic evaluation of health promotion and 
public health intervention in general, and specifically for 
older people shows that the following criteria are dis-
cussed as being most important and should be consid-
ered or at least reflected on for this specific target group 
[3]:
1. The appropriate measurement and valuation of infor-
mal caregiving (e.g. [11–13]);
2. The appropriate measurement and valuation of pro-
ductivity costs (including unpaid work) (e.g. [14–
16]);
3. Effects of the inclusion of costs unrelated to the inter-
vention that incur in life years gained by an interven-
tion (e.g. [17–19]);
4. The inclusion of ‘beyond-health’ benefits and/or the 
consideration of specific preferences of older people 
(in relation to social needs and health values) [20–
24].
These four criteria thus serve as the analytical frame-
work in this paper for assessing economic evaluation 
studies of health promotion activities for older people. 
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They will be outlined in more detail in the following sec-
tion. This review analyses whether and how they have 
been considered—or at least discussed—and what gen-
eral statements can be made on the informative value 
of the included studies, especially with regard to com-
parability. We discuss why these criteria are important 
and why their omission in most of the assessed studies is 
problematic.
Informal caregiving Informal care is relevant for the 
evaluation of health promotion for older people in a soci-
etal perspective in two respects. On the one hand, they 
may receive informal care. As it is often a defined target 
of health promotion for older people to avoid dependency 
on long-term care, informal care refers to direct non-med‑
ical costs that may be reduced by an intervention. This 
might be a reduction in informal caregiving time and/or 
effects on the health and well-being of the informal carer 
(e.g. [11, 13]). On the other hand, older people are also 
providers of informal care, and in this respect a valuation 
of costs of informal caregiver time could be considered as 
part of the indirect or productivity costs of an intervention 
(see next section).
Productivity costs Productivity costs usually represent 
the economic productivity lost due to death and lost or an 
impaired ability to work or to engage in leisure activities 
due to morbidity [25]. Whether and to what extent these 
costs should be included in health economic evaluations 
is controversial in theory and practice [14]. Whether they 
are included at all depends ultimately on the normative 
framework of the evaluation. A welfarist perspective will 
include productivity costs; an extra-welfarist perspective 
will not weight health gains against productivity costs. 
A central argument relating to interventions for older 
people is that if productivity costs are included, costs for 
unpaid work have to be included as well; otherwise the 
societal value of seniors’ (mostly) unpaid work, e.g. vol-
unteer work, household work and informal care, will be 
neglected. If the cost–effectiveness of interventions for 
older people is compared to cost–effectiveness results of 
interventions for younger people that include productiv-
ity costs, interventions for older people will be disadvan-
taged if the social value of their (unpaid) production is not 
considered [16].
Unrelated cost in added life years While there is a con-
sensus that future medical and non-medical costs that 
incur in life years gained by and related to an interven-
tion should be included in the cost analysis, there is an on-
going methodological debate over whether future costs 
that are unrelated to the intervention should be included 
(e.g. [17–19]). This refers to costs that occur as an indi-
rect result of interventions that successfully prolong the 
life-span, for example higher costs for long-term care or 
health care costs that would not have occurred in a shorter 
life. With regard to the assessment of interventions for 
older people this is important, because when compared 
to interventions for younger people life-prolonging inter-
ventions for older people will be rated less cost–effective 
if these costs are included. The reason for this is that the 
present value of these costs will be higher due to their 
occurrence in the near future, while these costs will be 
valued lower for younger persons because future costs are 
discounted.
‘Beyond‑health’ benefits and specific preference structures 
of older people As mentioned above, the goals of health 
promotion interventions are often not limited to indi-
vidual health gains, but comprise ‘beyond-health’ benefits 
as well. Especially for older people, it is often difficult to 
distinguish between health needs and social needs, thus 
the social benefit of an intervention may often outweigh 
the health benefit. Integration into the community, inclu-
sion, or increasing mobility are not always associated with 
an immediate improvement in health status, but they can 
be crucial outcomes of a health promotion programme. 
Social isolation, on the other hand, is negatively associ-
ated with health status and health-related quality of life 
in older people [26]. So while ‘beyond-health’ benefits are 
relevant for any target group, the crucial point here is that 
their importance increases for older people. Moreover, 
when valuing or comparing the effects of health promo-
tion interventions it should be considered that older peo-
ple (may) have different preferences than younger people 
[22, 27].
The identification of outcomes is not a primary task of 
health economic evaluations, but it is a specific require-
ment of health economic evaluations to condense the 
effects of an intervention to an outcome parameter that 
can be compared with costs. In the health economic 
evaluation of curative interventions by cost–effective-
ness analysis (CEA) or cost–utility analysis (CUA) social 
outcomes are usually not considered. But in the assess-
ment of health promotion—especially for older peo-
ple—benefits may be underrated if such outcomes are 
not accounted for. It is especially a problem of the com-
monly used quality-adjusted life year (QALY) that it does 
not capture social benefits, and is especially inappropri-
ate for covering the preference structures of older people, 
who for example regard physical functionalities as less 
important than younger people [20–22]. For these rea-
sons it is important to assess whether and how social or 
general ‘beyond-health’ benefits are taken into account in 
health economic evaluations of health promotion inter-
ventions for older people if alternatives to the QALY are 
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considered in cost–utility analyses, whether these prob-
lems are discussed at all—or at least mentioned.
Methods
Methodological challenges of the economic evaluation 
of health promotion interventions for older people were 
identified by means of an analysis of a broad range of the-
oretical and methodological literature. Four issues were 
identified as most important with regard to the compara-
bility and adequacy of economic studies. These four cri-
teria will be applied as assessment criteria to analyse the 
studies included in a systematic review on the economic 
evaluation of health promotion and primary prevention 
interventions for older people [4].
Systematic review of empirical studies
Within the original systematic review five electronic 
databases (MEDLINE via PubMed, EMBASE, The 
Cochrane Library, National Health Service Economic 
Evaluation Database, Health Technology Assessment 
Database via the Centre for Review and Dissemination) 
and the Internet websites of 23 institutions or projects 
related to the topic were searched for relevant articles. At 
a later stage, the reference lists of relevant papers were 
also screened. The database searches were conducted in 
July 2015; Internet websites of relevant institutions and 
projects were screened in the period August–September 
2015 [4]. The review has been updated using the same 
data sources in March 2018.1 Search terms included vari-
ous synonyms relating to older ‘population’ groups, 
health promotion OR primary prevention ‘intervention’ 
and economic evaluation as a ‘type of study’. The studies’ 
eligibility criteria included: (1) a target population of 
65  years or older, (2) interventions classified as health 
promotion or primary prevention, (3) a full economic 
evaluation conducted. The studies included were those 
available in English, Polish or German. Publication years 
range from 2000 to 2018.
In terms of participants, studies focussing on the gen-
eral population were only included if the outcomes were 
presented separately for any population group aged 
65+. The interventions of interest were health promo-
tion programmes whose scope was consistent with the 
1 The National Health Service Economic Evaluation Database and the 
Health Technology Assessment Database via the Centre for Review and 
Dissemination have not been searched as they are no longer updated since 
2015. The search in the databases and on websites identified 2.410 relevant 
citations. After removing duplicates 1.833 records were screened. Based on 
titles and abstracts 1.815 records were rejected. Based on full text analysis 
ten studies were excluded for not meeting the eligibility criteria. The most 
common reason for exclusion was the lack of separate outcomes for the 
population 65+ (six studies).
WHO definition of health promotion [28] and/or one of 
the types of health promotion interventions specified by 
McKenzie et  al. [29]. Primary prevention programmes 
were defined as those focused on precluding the initial 
occurrence of disease by risk reduction [30].
Two researchers assessed the eligibility of the studies 
independently of each other. Titles and abstracts were 
scrutinized to eliminate clearly irrelevant reports. The 
full text articles were obtained and appraised to ensure 
the compliance of the studies with the predetermined eli-
gibility criteria. The extraction of data from the eligible 
studies was conducted by two researchers independently 
of each other. Besides a general quality assessment of the 
included studies on the basis of the ‘Drummond checklist 
for assessing economic evaluations’ [25], an additional 
assessment was performed by the same researchers based 
on the set of additional criteria related to the special char-
acter of the economic evaluation of health promotion 
programmes for older people for the studies of the sys-
tematic review and the studies that resulted in the update 
of this review. This assessment included the criteria out-
lined above (societal perspective, consideration of infor-
mal caregiving, productivity costs/unpaid work, costs 
related to life years gained, ‘beyond-health’ effects). This 
was double checked by a third (independent) researcher. 
The studies were examined to establish whether these 
criteria were included and how, or whether their exclu-
sion is discussed as part of the studies’ limitations.
More information on the systematic review, including 
a detailed description of the studies under review and 
the general quality assessment, can be found in Dubas-
Jakóbczyk et al. [4].
Results
In addition to twenty-nine relevant studies that had been 
identified in the systematic review, eight studies have 
been identified in the update of the literature search, 
so thirty-seven studies are included in this assessment. 
The majority (n = 25) of the studies were economic 
evaluations of fall prevention strategies for older people 
[31–55]. Five studies focussed on problems of general or 
mobility disability [56–60], two on general health status 
[61, 62], two on lack of physical activity [63, 64], one on 
frailty [65], one on mental wellbeing [66] and a further 
one on oral health [67]. Regarding the economic evalu-
ation methods used, 29 of the studies were CEAs, two 
included several natural outcome indicators [cost–con-
sequence analyses (CCA)], and twelve included CUA 
as well. Five studies were CUAs alone and the remain-
ing three studies were cost–benefit analyses (CBA), but 
only one of the CBAs included individual preferences by 
willingness-to-pay (WTP) rates for avoided mortality/
morbidity.
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The general quality of the studies was diverse, with 18 
out of the 37 studies meeting the criteria for good quality 
as defined by Dubas-Jakóbcyk et al. [4] using the Drum-
mond criteria. The most common problems were a lack 
of or imprecise information on particular elements of 
the economic evaluation process and the lacking inclu-
sion of all relevant costs and consequences in relation to 
the respective perspective of the study. Additional file 1: 
Table S1 provides an overview of the main general char-
acteristics of the studies included as well as a summary of 
the results of the assessment of the studies.
Figure 1 visualises the summarized result of the assess-
ment of the studies with respect to special requirements 
for the economic evaluation of health promotion pro-
grammes for older people. It shows that these aspects 
were only considered in a very small number of studies. 
In general, the authors of the studies under review rarely 
included, discussed or commented on methodological 
problems resulting from the specific character of this 
type of evaluation. A societal perspective was adopted 
in only 13 of the 37 studies, and the tackling of the four 
specific challenges (see below) was attempted in less 
than half of the studies that claimed to take a societal 
perspective.
Informal care
Costs of informal care were taken into account in very 
few of the studies under review. Informal care was 
included as part of direct medical costs in only five of 
the 13 studies that claimed to take a societal perspective. 
One of these studies considered unpaid household work; 
the costs for this work were estimated by using nation-
ally published estimates for unpaid household work [51]. 
A second study considered informal care, valued by the 
price of professional help as a replacement price [46]. The 
third study, a modelling study, used estimates on infor-
mal care costs provided by another study that valued 
informal caregiving time as lost leisure time (i.e. 3 €/h) 
[47, 68]. The fourth study valued informal care on the 
basis of shadow prices for unpaid work [45]; and a fifth 
study considered the cost of ‘hiring a babysitter’ and ‘lost 
income of any companion who accompanied the partici-
pant’ during the time of the intervention [57], which is 
a very limited approach to considering informal caregiv-
ing costs as part of the indirect cost of the intervention 
itself (programme costs). Of the remaining seven studies, 
only one mentioned the exclusion of informal care costs 
as a limitation [58]. One study was situated in a nursing 
home, thus informal care costs were not applicable here 
[52]. The others did not even discuss or mention the 
topic. The methods of measuring or estimating the time 
provided by informal caregivers differed from study to 
study insofar as they were reported. Effects on the infor-
mal caregivers’ health or well-being were not considered 
at all.
Productivity costs
Among the studies taking a societal perspective, four out 
of 13 included some sort of valuation of the participants’ 
time as part of the cost assessment, thus may have con-
sidered some kind of ‘productivity costs’. Three of these 
studies valuated only the time spent on the intervention 
as part of the implementation costs of the programme 
[47, 57, 63]. Only one study valuated the participants’ 
time spent in receipt of care, and thus included long-
term effects of the intervention [46]; however, it did 
Fig. 1 Frequency of the consideration of the assessed criteria in the included studies. *Not included, but mentioned as part of the study limitation 
or justification for exclusion provided (e.g. lack of data for calculation)
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not provide any explanation or details as to how this 
was done. Apart from that, one single study mentioned 
the exclusion of older people’s time or production as a 
shortcoming of the study [62]. Two studies argued that 
productivity losses do not have to be assessed if the 
study population is predominantly retired [45, 60]. For 
one CBA it can be argued that these indirect costs were 
implicitly included as part of the valuation of WTP for 
averted morbidity and mortality [52].
The three studies that valuated the time spent on the 
intervention each used different methods. Only in one 
study were participants asked what they gave up to par-
ticipate in the programme in question, so only this study 
provided a differentiated analysis with respect to paid 
work, volunteer work and informal care [63]. One study 
considered only the lost formal income of the participant 
or his/her companion or a possible baby-sitter’s wage 
[57]. One study valued the participants’ time as leisure 
time.
Unrelated costs in added years of life
Only two studies considered costs for long-term care and 
health care in gained years. One study included these 
costs in one version of its evaluations and it was shown 
that they had a substantial negative effect on the net ben-
efit of the intervention; on the other hand, productivity 
or other social or individual benefits of time gained were 
not valued (though claiming a societal perspective) [62]. 
Still the authors concluded that in their (Swedish) policy 
context it did not seem reasonable from a public-deci-
sion making perspective to include this cost component. 
The other study developed a cost–effectiveness model to 
predict publicly funded health and aged care costs and 
QALYs over the remaining lifetime of frail older per-
sons. While the model includes costs and QALY-benefits 
in gained years of life, the main concern of the study is 
the inclusion of long-term effects of interventions that 
are often disregarded due to the short observation peri-
ods. This study used the Markov model to predict pub-
licly funded health and social care costs and QALYs to an 
age of 100 years maximum. The use of this model means 
that in the case of an intervention leading to life exten-
sion additional costs in gained years of life are included. 
Applied to the analysed physiotherapy-based interven-
tion, effects on mortality were in fact negligible, so the 
added costs did not occur (however, the method used 
allows their inclusion) [65].
Outcomes: inclusion of ‘beyond‑health effects’
Regarding the inclusion of ‘beyond-health’ effects, most 
studies included in the review used avoidance measures, 
like ‘falls prevented’, health status measures, or QALYs as 
outcome measures. When QALYs were used, however, no 
attempt was made to adjust for the preference structure 
of elderly which might differ significantly from the rest of 
the population. There were only two studies that included 
indicators of social benefits. The study by Iliffe et al. [63] 
included ‘self-efficacy for exercise’ and ‘social network 
size’ as additional indicators. The study by Mountain 
et al. [66] included ‘loneliness’, ‘general self-efficacy’ and 
‘general well-being’ as secondary outcomes, in addition 
they assessed serious adverse events and whether they 
were related to the intervention. In the CBA by Wilson 
and Datta [52] social benefits may have been included to 
a limited extent by WTP for the avoidance of morbidity 
and mortality. Only four additional studies mentioned 
that there were social or intersectoral benefits that had 
not been considered [43, 44, 47, 62]. Johansson et  al. 
[47], as one example, mentioned that cost–effectiveness 
may be underestimated because positive externalities of 
the programme were not considered. These may include 
a reduction of injuries in other age groups, due to the 
removal of street hazards, or increased social networks. 
Sahlen et  al. [62] on the other hand merely mentioned 
that there may have been an ‘enjoyment’ factor compen-
sating for the value of time used that had not been con-
sidered as well.
The limited comparability of results with interventions 
for other age groups, especially for studies that refer to 
QALYs as outcome indicators, was not mentioned in any 
of the studies.
Discussion
In general, the analysis of the existing evidence on the 
economic evaluation of health promotion and primary 
prevention actions addressing older population groups 
showed huge differences in the methods applied as well 
as the overall quality of the studies [4]. The economic 
evaluations performed are very heterogeneous in relation 
to cost categories included and the presentation of out-
comes. Therefore, the comparability of results is on the 
whole quite limited. Although the societal perspective 
is recommended for the economic evaluation of health 
promotion interventions, only 13 studies include this 
approach. Still, some of these studies do not differ from 
studies that claim to assume a patient/provider perspec-
tive with regard to costs and benefits included. These 
findings corroborate results discussed by Davis et al. [34] 
who argue that comparability of fall prevention studies 
is limited and seek to establish guidelines for conducting 
and reporting respective economic evaluations.
Heterogeneity is particularly obvious when it comes to 
the consideration of cost categories and outcomes that 
need special attention for health promotion interventions 
aiming at older people. This clearly indicates the need for 
a standard practice for conducting economic evaluations 
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for health promotion interventions for older people. The-
oretical debates on specific requirements of economic 
evaluations for this target group are rarely reflected on in 
economic evaluation practice so far.
Informal care
Research on the economic valuation of informal care has 
developed significantly over the last 10–15 years, but as 
yet this is not sufficiently reflected in applied health eco-
nomic evaluations studies. Given the heterogeneity of 
methods used to include informal care, more research on 
the impact of different methods and an increasing con-
sensus on how to value informal care, i.e. by the develop-
ment of guidelines and/or reference cases, is necessary to 
attain a better comparability of results [11, 12, 69]. Given 
that it is often a defined target of health promotion inter-
ventions for older people to sustain self-sufficiency and 
avoid dependency on long-term care, costs for informal 
care should be included as part of the direct non-medical 
costs that may be avoided by an intervention. This com-
prises costs that are incurred to facilitate informal care 
and the valuation of the time spent by the uncompen-
sated care-giver. Against the background of the missing 
consensus concerning the methods to assess informal 
care, and only a limited knowledge so far on the influ-
ences of the different methods on the cost–effectiveness-
ratios, it is advisable to assess the impact of the inclusion 
by sensitivity analyses. If costs of informal care are not 
included in the study a sufficient explanation should be 
provided [12]. Effects on the health or well-being of the 
care-giver should be considered on the effect side of the 
economic evaluation.
If productivity costs are included (see below) informal 
care has to be considered as a value of ‘work-time’ lost or 
gained due to an intervention. This refers to indirect ‘pro-
gramme costs’, i.e. value of time spent on the intervention 
itself as well as paid or unpaid ‘production loss’ or gain.
Productivity costs
The inclusion of productivity costs in health economic 
evaluations is controversial. As mentioned above, their 
inclusion is dependent on the normative framework of 
a study, and national health economic guidelines dif-
fer widely in their requirements and recommendations 
with regard to productivity costs in general and unpaid 
work in particular [70, 71]. A study by Krol and Brower 
on the general role of productivity costs related to unpaid 
work in current health economic evaluations confirms 
a general lack of awareness concerning these costs. This 
is reflected by a lack of clear guidance on how to meas-
ure and value lost unpaid work in major health economic 
textbooks and national health economic guidelines [70]. 
Concerning studies on elderly patient populations they 
conclude that it seems to be common reasoning “that 
productivity costs are irrelevant since patients are too old 
to be in paid profession” (ibid. 128).
Thus there are three reasons why the representation 
of productivity costs is unsatisfactory in health eco-
nomic evaluations for older people. Firstly, the inclu-
sion of productivity cost is contentious per se and not 
always required by national guidelines. Secondly, there is 
no consensus and a lack of guidance on how to measure 
and value productivity appropriately—in particular with 
regard to unpaid work. This is especially challenging if 
productivity costs are not only considered as part of the 
implementation costs of an intervention, but also com-
prise the long-term effects of an intervention. Thirdly, 
there is a disregard of productivity costs, because it is 
assumed that they are not relevant for this specific tar-
get group, which neglects the societal value of seniors’ 
unpaid work.
A discussion of the implications of different options of 
including productivity cost and especially unpaid work 
as part of productivity costs is beyond the scope of this 
paper. For future research it may be a starting point to 
report productivity costs separately from direct costs 
in order to allow a comparison of outcomes between 
studies. It may not be necessary—or due to lacking data 
feasible—to include productivity costs in every study; 
nevertheless, the non-inclusion of productivity costs 
should be justified very carefully. The omission of a dif-
ferentiated analysis of productivity costs in the economic 
evaluation of interventions for older age groups will be 
problematic if study results are compared to those of 
interventions aiming at younger age groups that include 
productivity costs.
Unrelated costs in added years of life
The study in the review that considers costs for long-term 
care and health care in gained years in one version of its 
evaluations [62] shows that this has a significant effect 
on the net benefit of the intervention. These aspects 
and their possible discriminatory effects on interven-
tions aiming at older people will need further attention 
in future research, as the inclusion or exclusion of unre-
lated future medical and long-term care costs may have 
notable distributional consequences [19], especially for 
interventions that increase the longevity of older people.
‘Beyond‑health’ benefits and specific preferences of older 
people
The assessment of the studies under review shows that 
beyond-health benefits are taken into account only to 
a very limited extent; and for the most part respective 
problems are not even mentioned. Limitations of the 
QALY to cover health benefits of older people or specific 
Page 8 of 11Huter et al. Cost Eff Resour Alloc  (2018) 16:14 
preferences of older people that may limit the compara-
bility of the study results were not mentioned at all.
As it is methodologically challenging to include diverse 
effects in an economic evaluation compared to the assess-
ment of a simple proxy indicator such as ‘number of falls 
prevented’, and social or beyond-health benefits are rarely 
included in health economic evaluations in general, it 
would be desirable that authors at least mention these 
problems, which is done in only very few studies.
One main reason for the omission of beyond-health 
effects is the methodical demand for economic studies 
to condense effects to a quantifiable outcome indicator. 
As yet, there is only scant methodological guidance on 
how to include social benefits in economic evaluations 
beyond cost–benefit analyses. Methodological guide-
lines were originally developed for clinical interventions, 
where social benefits are not usually taken into account. 
Most of the studies included in this review concern fall 
prevention—interventions with a clearly defined primary 
objective. As these are relatively similar to clinical inter-
ventions—compared to complex multi-layered health 
promotion or public health interventions—the necessity 
to include further-reaching effects may have appeared 
negligible. This might be true if the cost–effectiveness of 
fall prevention interventions is proven without consider-
ing social benefits, but the comparability of these results 
nevertheless remains limited. Thus, even when compar-
ing results of different fall-prevention interventions it is 
beneficial to take into account in the cost–effectiveness 
assessment as to which interventions entail additional 
social benefits.
The QALY that comprises multidimensional health 
benefits is an approved outcome indicator in many 
national health economic guidelines. Its inclusion as 
an outcome indicator reflects the endeavour to achieve 
comparability with other interventions. Methodologi-
cal debates on their limited capability to adequately cap-
ture quality-of-life gains for older people have only in 
recent years been reflected in attempts to develop more 
adequate outcome indicators. It is essential that concepts 
are developed that include beyond-health benefits and 
specific preferences of older people in health economic 
studies. One promising approach is the use of instru-
ments such as ICECAP-O or ASCOT, which have been 
developed in recent years to measure the well-being of 
older people on the basis of their preferences (e.g. [24]). 
These instruments are recommended for use, for exam-
ple, in economic evaluations of social care by the British 
National Institute for Health and Care Excellence [72]. 
Some authors recommend the use of cost consequence 
analysis in economic assessments in the field of health 
promotion, public health or other complex interven-
tions [1, 73, 74]. Benefits such as, for example, general 
well-being, maintenance of independence, social inclu-
sion, and safety are very relevant potential outcomes of 
health promotion interventions targeting older people; 
their ignorance might lead to an underestimation of their 
positive effects in economic evaluations.
Walter et al. [75] published a feasibility study in Decem-
ber 2017 on a home-based health promotion interven-
tion for older people with mild frailty, that included an 
economic evaluation. Their conclusion is that a full ran-
domized controlled trial including an economic evalu-
ation of this intervention is feasible. The study included 
ICECAP-O and general well-being measures, considered 
informal care as part of the cost assessment, and while 
not explicitly referring to productivity costs, the time 
of the participants spent on caring responsibilities was 
at least reported. The study thus supports our claim for 
the inclusion of the categories discussed in this article in 
health economic evaluations and gives reason for hope 
for future studies with such a perspective.
Conclusions
Overall, this assessment shows clearly that there is no 
established practice for conducting economic evaluations 
of health promotion interventions for older people from 
a societal perspective. Theoretical debates on specific 
requirements of the economic evaluation of interven-
tions for older people have not permeated in the majority 
of applied health economic evaluations. Cost categories 
that are important for the economic evaluation of health 
promotion for older people are only partly reflected, and 
if they are considered, the methods used are very hetero-
geneous. Thus, there is a strong need for guidelines and 
reference cases to achieve better comparability. Social 
benefits are included only to a very limited extent; diver-
gent preferences of older people are not considered at all. 
Instruments that have been developed in recent years to 
measure the well-being or specific preferences of older 
people are not yet used in existing studies. Their incorpo-
ration into future economic evaluations would be highly 
beneficial.
The authors of the existing studies only seldom analyse 
or comment on the limitations resulting from the direct 
application of economic evaluation methods typical for 
clinical interventions in the area of health promotion for 
older people.
We conclude:
  • Methodological challenges are not sufficiently met in 
existing studies so far.
  • A comparison of results of different economic evalu-
ations, even of similar interventions, has to be car-
ried out with great caution.
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  • A comparison of the cost–effectiveness results with 
other interventions or results for other age groups is 
not possible and therefore not advisable.
In order to deal with the specific problems of the eco-
nomic evaluation of health promotion activities for the 
elderly, studies should address the four criteria described 
above. We recommend that these criteria should be 
included in the future quality assessment of health eco-
nomic evaluations. Since no generally accepted practice 
exists as to how these criteria should be included, more 
research is necessary on the different approaches for their 
inclusion and on their respective effects on the outcomes. 
Disregarding these problems could implicitly lead to a 
discrimination of health promotion and disease preven-
tion against older people and thus an age-based ration-
ing of public health care. Health economic studies should 
at least be completely transparent regarding the methods 
they use to include these costs, or thoroughly justify why 
some cost categories may have been excluded.
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